DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Slamon DJ, Eiermann W, Robert NJ. et al.
Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC -> T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC -> TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+early breast cancer.

Cancer Res 2016;
DOI: 10.1158/1538-7445.SABCS1115-S1155-1104.

Download Bibliographical Data

Search in: